DXL, FullBeauty to merge

The companies see opportunity in an underserved and fragmented market, despite the rising use of GLP-1 drugs.

The companies see opportunity in an underserved and fragmented market, despite the rising use of GLP-1 drugs.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.